相关实验视频
Updated: May 10, 2026
11:10
Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
在2型和1型糖尿病之间糖尿病酸性糖尿病的临床和预后差异
Maria Sara Tapia Sanchiz1, Victor Navas Moreno1, Marta Lopez Ruano1
1Servicio de Endocrinología y Nutrición, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid; Instituto de Investigación Sanitaria de La Princesa, Madrid, España.
Medicina clinica
|May 16, 2025
概括
糖尿病酸 (DKA) 在2型糖尿病 (T2D) 患者呈现出比1型糖尿病 (T1D) 更严重的诱发因素和更高的死亡风险,尽管血液气体标志物更好. 早期发现DKA对于预防并发症至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 临床研究 临床研究
背景情况:
- 糖尿病酸性酸症 (DKA) 是糖尿病的一个严重并发症.
- 了解1型糖尿病 (T1D) 和2型糖尿病 (T2D) 之间的DKA差异对于患者管理至关重要.
- 以前的研究还没有完全阐明DKA在T2D与T1D中的独特临床特征和结果.
研究的目的:
- 为了比较2型糖尿病 (T2D) 与1型糖尿病 (T1D) 患者糖尿病酸症 (DKA) 的临床特征和结果.
- 确定与不同类型糖尿病中DKA死亡率相关的特定风险因素.
- 在多样化的糖尿病人群中为DKA的管理提供临床实践的信息.
主要方法:
- 追溯队列研究分析了西班牙第三级医院2010-2024年的DKA病例.
- 在患有DKA的T2D和T1D患者之间收集和比较临床和实验室变量.
- 后勤回归分析以确定DKA事件后30天死亡率预测因素.
主要成果:
- 这项研究包括249名患者 (35.7%T2D,64.3%T1D).
- 在T2D患者中,DKA显示出更高的心血管预发事件发生率和更有利的血液气体概况 (更高的pH,二碳酸盐;较低的酸盐).
- 尽管最初的血液气体概况更好,但T2D组的30天死亡率明显高 (13.5%),相比T1D组 (1.3%). 心血管事件,格拉斯哥昏迷度数较低,尿素水平较高预测死亡率.
结论:
- 在T2D中,糖尿病酸性脂肪酸与增加的死亡风险有关,这主要是由导致因素的严重程度驱动的,而不是最初的血液气体乱.
- 尽管看似不那么严重的代谢障碍,与T2D相关的DKA由于潜在的并发症和导致事件而构成更大的威胁.
- 迅速识别和管理DKA发作,考虑到每个糖尿病类型的特定风险因素,对于改善患者的治疗结果和降低死亡率至关重要.
相关概念视频
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:25Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...